NCT04793113 is a NA clinical trial of FreshlyFit Meals in Weight Loss, sponsored by Freshly, Inc..

Who is sponsoring NCT04793113?

NCT04793113 is sponsored by Freshly, Inc..

What drugs are being tested in NCT04793113?

Interventions in NCT04793113: FreshlyFit Meals.

What condition does NCT04793113 study?

NCT04793113 studies Weight Loss.

Is NCT04793113 still recruiting?

NCT04793113 is currently status unknown. Last updated 12 March 2021.

Last reviewed 2021-03-12 · How we verify

NCT04793113

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study to Assess the Effects of Freshly Fit Meals on Body Weight and Wellness in Overweight and Obese Adults

Status unknown NA Last updated 12 March 2021

What this trial tests

NA trial testing FreshlyFit Meals in Weight Loss in 50 participants. Status unknown.

Timeline

15 March 2021

Primary endpoint
23 September 2021

23 September 2021

Quick facts

Lead sponsor	Freshly, Inc.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	50
Start date	15 March 2021
Primary completion	23 September 2021
Estimated completion	23 September 2021
Sites	1 location across United States

Drugs / interventions tested

FreshlyFit Meals

Conditions studied

Weight Loss — all drugs for Weight Loss →

Sponsor

Freshly, Inc.

Who can join

Adults 21 to 55, any sex, with Weight Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this trial is to examine the weight-loss efficacy of Freshly Fit meals, as well as body composition, waist/hip circumference, metabolic markers, and quality of life in overweight and obese adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Weight Loss

Currently open trials in the same condition.

NCT06811324 — Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults · Phase 2 · recruiting
NCT07223983 — Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS) · Phase 1 · recruiting
NCT07213466 — Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder · Phase 4 · recruiting
NCT06785064 — Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance · NA · recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04793113 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Freshly, Inc.
Last refreshed: 12 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04793113.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing